These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 18440232)
1. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Cheng XC; Wang Q; Fang H; Tang W; Xu WF Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Cheng XC; Wang Q; Fang H; Tang W; Xu WF Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors. Cheng XC; Wang Q; Fang H; Tang W; Xu WF Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors. Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors. Mou J; Fang H; Liu Y; Shang L; Wang Q; Zhang L; Xu W Bioorg Med Chem; 2010 Jan; 18(2):887-95. PubMed ID: 19969464 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases. Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors. Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146 [TBL] [Abstract][Full Text] [Related]
8. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides. Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784 [TBL] [Abstract][Full Text] [Related]
9. Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I). Li Y; Zhang J; Xu W; Zhu H; Li X Bioorg Med Chem; 2010 Feb; 18(4):1516-25. PubMed ID: 20097082 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors. Li SH; Li G; Huang HM; Xiong F; Mai X; Kuang BH; Liu CM; Tu GG Pharmazie; 2009 Feb; 64(2):67-70. PubMed ID: 19320275 [TBL] [Abstract][Full Text] [Related]
11. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I). Li X; Wang J; Li J; Wu J; Li Y; Zhu H; Fan R; Xu W Bioorg Med Chem; 2009 Apr; 17(8):3053-60. PubMed ID: 19329328 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of an orally active matrix metalloproteinase inhibitor. Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors. Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297 [TBL] [Abstract][Full Text] [Related]
14. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II). Li X; Wang Y; Wu J; Li Y; Wang Q; Xu W Bioorg Med Chem; 2009 Apr; 17(8):3061-71. PubMed ID: 19339187 [TBL] [Abstract][Full Text] [Related]
15. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN). Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors. Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099 [TBL] [Abstract][Full Text] [Related]
18. The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors. Li SH; Li G; Huang HM; Xiong F; Liu CM; Tu GG Arch Pharm Res; 2008 Oct; 31(10):1231-9. PubMed ID: 18958412 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors. Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs). Zhang YM; Fan X; Yang SM; Scannevin RH; Burke SL; Rhodes KJ; Jackson PF Bioorg Med Chem Lett; 2008 Jan; 18(1):405-8. PubMed ID: 17980583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]